BridgeBio Pharma, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US10806X1028
USD
74.76
3.3 (4.62%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
-1,467.90
-1,354.26
-1,254.62
-870.41
57.91
408.45
Shareholder's Funds
-1,467.90
-1,354.26
-1,254.62
-870.41
57.91
408.45
Minority Interest
10.29
11.72
9.69
4.83
49.98
67.52
Long-Term Borrowings
2,205.12
1,730.86
1,711.29
1,709.04
481.11
99.79
Secured Loans
2,205.12
1,730.86
1,711.29
1,709.04
481.11
99.79
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Other Long Term Liabilities
22.08
18.34
38.92
39.5
24.2
3.53
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
2,222.55
1,745.07
1,746.53
1,743.30
500.05
95.32
Current Liabilities
Trade Payables
9.62
10.65
11.56
11.88
8.95
8.85
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Liabilities
154.40
143.84
121.43
135.07
95.65
60.38
Total Liabilities
919.34
546.38
623.04
1,012.79
703.59
631.68
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
0.00
0.00
0.00
0.00
0.00
0.00
Less: Accumulated Depreciation
0.00
0.00
0.00
0.00
0.00
0.00
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
12.78
19.84
25.25
45.97
36.83
5.62
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
145.76
3.74
2.87
2.42
2.60
31.57
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
16.18
18.88
17.36
30.61
21.33
25.86
Total Non-Current Assets
198.65
68.79
74.18
123.93
60.76
63.06
Current Assets Loans & Advances
Current Investments
0.00
58.95
95.23
442.89
251.01
182.22
Inventories
0.00
0.00
0.00
0.00
0.00
0.00
Sundry Debtors
4.72
1.75
17.08
19.75
0.00
0.00
Cash and Bank
681.23
392.59
414.62
393.95
356.08
363.77
Other Current Assets
685.95
453.29
526.93
856.59
607.09
545.99
Short Term Loans and Advances
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Assets
720.69
477.59
548.85
888.86
642.82
568.62
Net Current Assets (Including Current Investments)
566.29
333.75
427.42
753.79
547.18
508.24
Total Current Assets Excluding Current Investments
720.69
477.59
548.85
888.86
642.82
568.62
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
919.34
546.38
623.04
1,012.79
703.59
631.68
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
2,205.12
1,730.86
1,711.29
1,709.04
481.11
99.79
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Dec 2024 is 27.44% vs 1.12% in Dec 2023

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Dec 2024 is 20.39% vs -52.88% in Dec 2023

stock-summary

Fixed Assets

YoY Growth in year ended Dec 2024 is -35.58% vs -21.43% in Dec 2023

stock-summary

Investments

YoY Growth in year ended Dec 2024 is 3,797.33% vs 30.31% in Dec 2023

stock-summary

Current Assets

YoY Growth in year ended Dec 2024 is 50.90% vs -12.98% in Dec 2023

Compare Balance Sheet Results of BridgeBio Pharma, Inc.
Markets Mojo
Figures in Million
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
-1,467.90
710.13
-2,178.03
-306.71%
Shareholder's Funds
-1,467.90
710.13
-2,178.03
-306.71%
Minority Interest
10.29
0
10.29
0.00%
Long-Term Borrowings
2,205.12
9.29
2,195.83
23,636.49%
Secured Loans
2,205.12
9.29
2,195.83
23,636.49%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
0
0
0.00
0.00%
Other Long Term Liabilities
22.08
90.87
-68.79
-75.70%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0
0
0.00
0.00%
Total Non-Current Liabilities
2,222.55
90.87
2,131.68
2,345.86%
Current Liabilities
Trade Payables
9.62
12.91
-3.29
-25.48%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0
0
0.00
0.00%
Total Current Liabilities
154.40
117.63
36.77
31.26%
Total Liabilities
919.34
918.64
0.70
0.08%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
0
432.90
-432.90
-100.00%
Less: Accumulated Depreciation
0
122.97
-122.97
-100.00%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
12.78
309.94
-297.16
-95.88%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
145.76
0
145.76
0.00%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
16.18
4.13
12.05
291.77%
Total Non-Current Assets
198.65
334.25
-135.60
-40.57%
Current Assets Loans & Advances
Current Investments
0
49.34
-49.34
-100.00%
Inventories
0
83.11
-83.11
-100.00%
Sundry Debtors
4.72
87.86
-83.14
-94.63%
Cash and Bank
681.23
344.07
337.16
97.99%
Other Current Assets
685.95
564.37
121.58
21.54%
Short Term Loans and Advances
0
0
0.00
0.00%
Total Current Assets
720.69
584.39
136.30
23.32%
Net Current Assets (Including Current Investments)
566.29
466.75
99.54
21.33%
Total Current Assets Excluding Current Investments
720.69
584.39
136.30
23.32%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
919.34
918.64
0.70
0.08%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
2,205.12
9.29
2,195.83
23,636.49%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Borrowings 2,200.47 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 27.44% vs 1.12% in Dec 2023

Annual - Other Long Term Liabilities
Other Long Term Liabilities 22.08 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 20.39% vs -52.88% in Dec 2023

Annual - Fixed Assets
Fixed Assets 12.78 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -35.58% vs -21.43% in Dec 2023

Annual - Investments
Investments 145.76 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 3,797.33% vs 30.31% in Dec 2023

Annual - Current Assets
Current Assets 720.69 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 50.90% vs -12.98% in Dec 2023